Member Info for roger65

6 machines is not going to make any difference in the long run Gloria. one report coming from either of the two hospitals that it has worked and prevented a child from being born and others will happily buy. As someone else stated a couple of days ago, imagine you are a parent with a child who is born deaf and then you learn that a hospital in the neighbouring County has a machine that could easily (a 99.2% chance) prevented that. There would be law suits galore and it's not as if any hospitals worth their reputation can say they didn't know about it. They have researchers whose job it is to constantly look for the best and newest treatments on offer. For something like this that can have such a profound impact on the lives of thousands of lives I'd say the price will be worth paying.

45p! If we stay at this level or drop further then I will consider lowering it more. One good bit of news and I've experienced more than once how quickly this stock can fly.

bigbench - £35m for sales in the Uk AND the EU. The population of the two combined is bigger than the US so I would roughly estimate the potential revenue from the US as being the same, but hey, that's another £35m! That doesn't include Canada.

None of this takes into account potential revenue from the Middle East, South America or other wealthy Asian territories such as Japan and South Korea. It's potential is huge.

Don't the BRICS countries want to see the end of the US dollar as the global reserve currency? If that's the case then might a buyer for EUA's assets end up paying in something other than US dollars? And if so, how would funds for a sale make its way back to UK share holders?

I know DS was working on a blockchain currency for commodities so perhaps that's where that will fit in to the story here. As long as it eventually makes its way back to us I don't care how.

Anyone with L2 able to say if it's still PEEL on the ASK please? If it is then you bet they've got someone lined up with large orders to fill.

Correct donotpanic. My buy of 10325 @ 24.1549p is marked down in red. I've just bought another lot of 10331 @ 24.14p. Interesting to see if that goes down as a sell too. Typical inaccurate reporting but it's very common unfortunately and for the novice investors it's rubbish as all they see is a sea of red and think there's some kind of sell-off. Pretty sure that's not happening here this morning.

AIHL revenue was estimated back in September, before Budd knew of interest from the US and Australia, as £35m for the UK and the EU. Here we are six months later and it now has been verified as outstandingly successful and we know there is no competition for it anywhere in the world. I imagine the revenue from the US and Australia alone would equal that of £35m and there are many more countries (not to mention private Health Services throughout the world) besides which may well want this kit. The research was published in the top Medical journal in the world (JAMA) and once some hospitals in any given country have it there will be pressure from all the others to have it as part of their routine care practice in neonatal departments. It's wonderful this product will help prevent thousands of babies around the world being born with deafness but ultimately it's the Governments of the developed countries who realise it will save them a fortune in the long run who are going to be purchasing it left, right and centre. It's a no brainer for them and so I put this current malaise in the sp down to Budd's track record in sales being so poor and the wider market and iis simply waiting to see more evidence of contracts in place and having some figures presented to them.

The AIHL product is now in a stronger position than the Covid POC products ever was and has a permanent market rather than being dependent on a global pandemic which comes and goes and will eventually weaken, to the point people can cope living normal lives with it being around.

GDR in a year's time is going to look like a very different proposition imo with incredibly significant revenue from AIHL and the Covid product always up its sleeve just in case. I'm ramping but I think the current sp is now too disconnected from the realistic potential of the company. just my view.

The market knows results for the previous 6 months won’t be good. It’s the investor presentation aspect that people will be focusing on. Positive revenue predictions we’ll seethe sp shoot up to 50+

Totally understand where you’re coming from Lloyd but if Budd announces more distribution agreements for the Covid POC product (we know of 4 currently), any sales, even modest figures, and then announced AIHl is expected to be purchased by all of the NHS Trusts and in EU countries as well as Australia (New Zealand?) and the US (Canada too?) then I doubt we’ll see 25p again. Let’s hope Budd is practising his most enthusiastic patter..

Having slept on it and taken a step back after receiving the news yesterday that the possible deal with the US DoD is now almost certainly dead in the water I’ve decided GDR is still a company with a couple of very strong products, one of which we’ve recently been told is going to be rolled out in the UK NHS and has interest from several other countries. That interest will quite quickly become global and the potential income will be significant! This, together with the fact Covid could spring up at any time and become seriously problematic again for all countries, makes me excited for the future with GDR. The 31st March is, after all, an investor presentation, so I’d expect DB to be making a strong case for people to invest in the company, not accentuate all the negatives. AIHL alone, if taken up pretty much globally will give GDR income levels within two years of £50m+ at least. There is no competition for the product so perhaps even countries such as India and China, the most populous on earth, will purchase AIHL kit - there are plenty of private health companies in these countries which serve their respective middle and upper classes so even that market is large.

If the sp falls further today I won’t panic, I’ll buy a little more and hope that Budd gives us the potentially great news on March 31st coated in optimism and laced with positivity!

Can’t believe that DB has yet again confounded the odds and is going to oversee another crash in the sp. So the US DoD contract came to nought. The eastern MoD likewise. Covid is all but done here in the uk so we’re now left with only the AIHL product to throw us a life line.

Miserable share this. Afraid this is going back into the teens tomorrow with that US news.

Most European countries have no relaxed their Covid restrictions so I think part of this current sell-off is due to investors realising news of sales in EU is highly unlikely. The thing we are now relying heavily on is AIHL product being bought up by every NHS Trust in the land and it becoming part of routine care practises in all developed countries health services. Didn't think the sell-off would be this severe though or this quick. My two buys today at. 27p and 25.5p both went down as red sells.

I just hope no one believed the idiotic rampers shouting that this was going to £1+. It might one day but not yet, unless Budd throws out some mega optimistic statements on the 31st.

* silence to reign...

It's a great shame that Budd never seems to have anything up his sleeve to keep positive momentum going. We get something good eg PAHOL study published and news that an NHS Trust is making GDR's kit part of their routine care measures and the sp lifts off, only for silent to reign once more and the sp has the life traded out of it.

If this US DoD order has been placed then it should be in an RNS. nearly $3m in revenue is news worthy and will have an impact on the sp. A positive one.

Please, please Budd, tell us of another 8 or 10 countries in the EU and ME that you have distribution agreements with, news of sales in Oman, UAE and Spain and Portugal and then that it looks as if all NHS Trusts in the UK will follow Manchester and that a whole host of other countries will also take up the AIHL kit. Think that would suffice for one day.

Oh and then we get CTDA news but as stated previously imv this won't do much for our sp.

Come on David Budd, it's time to stand and deliver please.

ps £30 - £50 per share??? Someone one was smoking something good that day...

that is good news. Well done! This with some news on more NHS Trusts in the UK taking the AIHL kit should finally prove that there is revenue coming in for the forseeable and that it's only going to increase for at least the next couple of years.

Now let's see PELL get off the ask and let it go for a while. Is today another day of mm carp? Absolutely possible they are holding sp down in order to let some larger buys get through at a lower price.

Regardless of positive news on AIHL (which I'm surprised has already seen the sp retrace to nearly the placing price of 25p) Budd has to deliver news on sales ie revenue.

We're on a bit of a knife edge here as no one knows what to expect. Two years ago Budd over promised and caused massive spikes in the sp. These days he's much more cautious, perhaps overly so, about what could be on the horizon for GDR. I wonder if he had his knuckles wrapped over some of the OTT statements he made. The one that sticks in my mind is 'the numbers add up dramatically'. It sent the sp soaring to over 150p only for him to deliver nothing for over a year.

News of sales on Covid POC kit in the EU or more NHS Trusts already committing to taking the AIHL kit (or indeed interest expressed from more countries in addition to Australia, Netherlands and the US) and this sp will hit 50p.

No sales - and therefore no income - and we fall back to 15p in short order. Obviously hoping for the sales news as I bought more at 27p and 28.3p to lower my average further. Still painfully in the red however at this point so it's a nervy time.

Tine for something from the BOD surely? It's been 2 months since the potential sale RNS. Since then nothing other than a BAU RNS. I guess that means there's nothing going on as per usual.

Absolutely. Sales are what will drive the sp. I think we've had as much as can be expected on AIHL news now and without further news on it being rolled out to NHS Trusts all over the UK we'll slowly sink again unfortunately. The wider market doesn't trust Budd after the last two or three years so he has much to prove in order to gain ii confidence. GDR still has no record of success regarding commercial sales. At the point we are informed of a sales agreement of something, somewhere - assuming the figures are good - the sp will go into overdrive.

BTW found out when we can expect the NICE guidelines? I thought this was lined up already and pending publication of the PAHOL report. Now that's out I was expecting it to drop fairly soon after but perhaps I'm wrong.

Next news.
NICE Guidance
more NHS Trusts to adopt AIHL kit
Health services in the EU to adopt AIHL kit
Application asap for its use in the USA (FDA)
News in the presentation of sales in the EU of the Covid POC kit as well as more distribution agreements (name more countries).
Be told what's is happening with Mountain Horse and US DoD.
I would also like to hear from Budd on whether or not once we actually gain CTDA approval in the UK if any plans will be made to sell that kit in the UK. It seems crazy to spend the time and money on submitting the application only to not try and sell it. I know we have been told the EU is the first priority but what if there aren't any sales in the EU? Would that mean we can shift focus to the UK quickly?

From all these questions it's clear that share holders need more communication from Budd and the BOD. Not long to wait now though and I think we'll get an idea of what the markets expect from Budd in the days just before March 31st. If it starts to tank then we know someone has got wind of no sales. If it starts to shoot up then, well, anything could happen with this stock. GLA

There won't be any orders landing in the US Bruno for a good while yet as it will need FDA approval, and that means it's probably at least a year away I'm afraid. Don't think there will be any short cuts either.

People shouldn't be surprised at a bit of a retrace today after over 100% rise on Friday. I'm hoping the presentation will have more news of NHS Trusts and hospitals ready to take the AIHL product, more distribution agreements in the EU for the Covid POC kit and maybe even news of a sale or two. I would dearly like to know what on earth happened to the US DoD matter too.

Now don't think CTDA will give us any further uplift as Budd has stated clearly he's planning on getting sales going in the EU first and not even going to try to sell it in the UK.

GLA genuine holders and just ignore the crazy and dim price predictions of £1 any time soon. That will only happen when we are given concrete news on sales and accompanying figures.

Tiger - this from you on Friday:
My prediction, £1.13 by mid week next week .

Priceless.

I did express an opinion yesterday which was of course roundly criticised by the wild rampers … quel surprise!

I did think mms would try really hard to push this down before letting it go any higher but I think it’sa good sign. They want in on the action and orders will be being placed now so expect some fun and games but I also expect it to eventually rise steadily back towards 40p by the time we get to the CEO’s presentation. After that? Who knows?